Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.22.2.2
Consolidated Statements of Operations - USD ($)
12 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Income Statement [Abstract]    
Revenues $ 42,333,000 $ 26,257,000
Cost of sales 35,034,000 20,467,000
Gross profit 7,299,000 5,790,000
Operating expenses:    
Selling and administrative 15,515,000 12,599,000
Research and development 7,141,000 6,669,000
Total operating expenses 22,656,000 19,268,000
Operating loss (15,357,000) (13,478,000)
Other income (expense):    
Other income 1,307,000
Interest expense (252,000) (622,000)
Net loss $ (15,609,000) $ (12,793,000)
Net loss per share - basic and diluted $ (1.01) $ (1.08)
Weighted average number of common shares outstanding - basic and diluted 15,439,530 11,796,217